Related Experiment Video
Updated: Jun 13, 2026
Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotypes
M Król1, K M Pawłowski, J Skierski
1Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland.
Abstract:
In light of the high incidence of mammary cancer in dogs and completion of the canine genome sequencing, the new possibilities of gene profiling by using DNA microarrays give hope to veterinary oncology. The cell lines isolated from mammary tumors are a valuable tool in developing and testing new pathway-specific cancer therapeutics. Differential cytometric analysis of 6 canine mammary cancer cell lines was performed. We divided cell lines into 3 groups based on their phenotype: 2 lines with high proliferative potential, 2 lines with high antiapoptotic potential, and 2 lines with high metastatic potential. DNA microarray analysis revealed common genes for cell lines of each group. We found that genes encoding the receptors for growth hormone and ghrelin are related to high proliferation rate, while ABR (active BCR-related) and TMD1 (TM2 domain containing 1) genes are related to a high antiapoptotic potential of the cancer cells. Metastatic properties of mammary cancer cells seem to be associated with elevated expression of PGP (P glycoprotein), SEMA3B (semaphorin 3B), and STIM1 (stromal interaction molecule 1).
Insights
Canine mammary cancer cell lines were analyzed using DNA microarrays to identify key genes. This research highlights specific gene profiles linked to proliferation, apoptosis resistance, and metastasis in dog breast cancer.
Area of Science:
- Veterinary oncology
- Comparative genomics
- Molecular biology
Background:
- Mammary cancer is prevalent in dogs, necessitating advanced research tools.
- Canine genome sequencing provides opportunities for gene profiling in veterinary oncology.
- Canine mammary cancer cell lines are crucial for developing targeted therapies.
Purpose of the Study:
- To identify gene expression patterns associated with distinct phenotypes in canine mammary cancer cell lines.
- To explore potential therapeutic targets by understanding the genetic basis of cancer cell behavior.
- To leverage DNA microarray technology for insights into canine mammary tumorigenesis.
Main Methods:
- Differential cytometric analysis of six canine mammary cancer cell lines.
- Categorization of cell lines into high proliferative, antiapoptotic, and metastatic groups.
- DNA microarray analysis to identify common genes within each phenotypic group.
Main Results:
- Genes for growth hormone and ghrelin receptors correlate with high proliferation.
- Active BCR-related (ABR) and TM2 domain containing 1 (TMD1) genes are linked to antiapoptotic potential.
- Elevated expression of P-glycoprotein (PGP), semaphorin 3B (SEMA3B), and stromal interaction molecule 1 (STIM1) is associated with metastatic properties.
Conclusions:
- Specific genes are identified as potential biomarkers for different canine mammary cancer behaviors.
- This gene profiling offers insights into pathway-specific therapeutic strategies for canine mammary cancer.
- Understanding these genetic associations can advance veterinary cancer treatment and research.
